These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16808256)

  • 41. Early non-immunological post transplant complications: a single center experience.
    Jabur WL; Mohammed Saaed HM; Abdulla K
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):651-7. PubMed ID: 18580032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategies to improve outcomes after renal transplantation.
    Baum CL; McGee AP
    N Engl J Med; 2002 Jun; 346(26):2089-92; author reply 2089-92. PubMed ID: 12088021
    [No Abstract]   [Full Text] [Related]  

  • 43. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.
    Nart A; Uslu A; Bozkaya G; Aykas A; Dogan M; Karaca B
    Transplant Proc; 2009 Mar; 41(2):751-5. PubMed ID: 19328972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z; Werstuck GH; Gerstein HC
    Rev Cardiovasc Med; 2007; 8(3):145-53. PubMed ID: 17938614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.
    Garg AX; Prasad GV; Thiessen-Philbrook HR; Ping L; Melo M; Gibney EM; Knoll G; Karpinski M; Parikh CR; Gill J; Storsley L; Vlasschaert M; Mamdani M;
    Transplantation; 2008 Aug; 86(3):399-406. PubMed ID: 18698242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Manifestation of metabolic risk factors after renal transplantation: III. Impact on cerebrocardiovascular complications.
    Jacobs U; Ferber J; Heimbach D; Klehr HU
    Transplant Proc; 1995 Jun; 27(3):2052-3. PubMed ID: 7792884
    [No Abstract]   [Full Text] [Related]  

  • 48. [Late complications following renal transplantation].
    Bemelman FJ; ten Berge RJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1317-21. PubMed ID: 18661857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Aggressive control of cardiovascular risk factors].
    Abrignani MG; Sclavo M
    Ital Heart J; 2004 Apr; 5 Suppl 4():25S-32S. PubMed ID: 15185475
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of overweight on kidney transplantation outcome.
    Sancho A; Avila A; Gavela E; Beltrán S; Fernández-Nájera JE; Molina P; Crespo JF; Pallardó LM
    Transplant Proc; 2007 Sep; 39(7):2202-4. PubMed ID: 17889137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular risk factors in the Mexican population.
    Garcia-Garcia G; Aviles-Gomez R; Luquin-Arellano VH; Padilla-Ochoa R; Lepe-Murillo L; Ibarra-Hernandez M; Briseño-Renteria G
    Ren Fail; 2006; 28(8):677-87. PubMed ID: 17162426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between obesity, hypertension and diabetes, and health-related quality of life among the elderly.
    Banegas JR; López-García E; Graciani A; Guallar-Castillón P; Gutierrez-Fisac JL; Alonso J; Rodríguez-Artalejo F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):456-62. PubMed ID: 17568249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The cardiovascular risk in kidney transplantation. The importance of cyclosporin A].
    Rodríguez Martín F; Sánchez Casajús A; Huarte Loza E; Gómez Alamillo C; Artamendi Larrañaga M; Sierra Carpio M
    Rev Clin Esp; 1995 Dec; 195(12):883-4. PubMed ID: 8599051
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term problems related to immunosuppression.
    López MM; Valenzuela JE; Alvarez FC; López-Alvarez MR; Cecilia GS; Paricio PP
    Transpl Immunol; 2006 Dec; 17(1):31-5. PubMed ID: 17157211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrovascular component of diabetes atherosclerosis and insulin (CUPS-18).
    Mohan V
    J Assoc Physicians India; 2007 Jul; 55 Suppl():13-8. PubMed ID: 17927006
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study.
    Tan JS; Wang JJ; Mitchell P
    Ophthalmic Epidemiol; 2008; 15(5):317-27. PubMed ID: 18850468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of risk factors for cardiovascular disease in Brazilian renal transplant recipients.
    Souza FC; Silva MI; Motta EM; Guimarães SS; Souza E; Torres MR
    Transplant Proc; 2007 Mar; 39(2):446-8. PubMed ID: 17362755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for vascular dementia in elderly psychiatric outpatients with preserved cognitive functions.
    Stella F; Banzato CE; Gasparetto Sé EV; Scudeler JL; Pacheco JL; Kajita RT
    J Neurol Sci; 2007 Jun; 257(1-2):247-9. PubMed ID: 17313960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategies to improve outcomes after renal transplantation.
    Friedman A
    N Engl J Med; 2002 Jun; 346(26):2089-92; author reply 2089-92. PubMed ID: 12088022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.